Skip to main content Skip to main navigation menu Skip to site footer

Lamotrigine-induced Stevens-Johnson Syndrome Toxic Epidermal Necrolysis (SJS/TEN) overlap with transaminitis in an Asian female: a case report


Background: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) is a dermatologic emergency characterized by extensive epidermal detachments. The most frequent etiology is drug reaction within an interval of the last 8 weeks. SJS/TEN may occur in any age, race, and gender; however, there is an increased risk in patients over 65. SJS and TEN are differentiated based on the extent of epidermal detachments, which is <10% in SJS, 10-30% in SJS-TEN overlap, and >30% in TEN. This case study aims to evaluate the Lamotrigine-induced Stevens-Johnson Syndrome Toxic Epidermal Necrolysis (SJS/TEN) overlap with transaminitis in an Asian female.

Case Presentation: A 34-year-old woman presented with a pruritic and burning rash on almost all body parts. The suspected causative drug was lamotrigine, which she consumed within the last 2 weeks. Mucosal involvement was also found on the lips and genital mucosal. The affected body surface area was approximately 20%, with a positive Nikolsky sign. Laboratory studies showed elevated liver function tests. Based on the history, physical examination, and biopsy, the patient was diagnosed with SJS/TEN overlap. The suspected causative drug was immediately stopped, and supportive and systemic corticosteroid treatments were provided. The SCORTEN was 2, with a mortality rate of 12.1%. After a few days, the patient's condition had improved, the liver function test was normal, and there was no significant complication.

Conclusion: SJS-TEN is a part of epidermal necrolysis, characterized by an extensive epidermal detachment. The management of SJS/TEN includes early detection, immediately stopping the suspected drugs, administering systemic corticosteroids, and other supportive treatments.


  1. Mockenhaupt M, Roujeau JC. Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis). In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS. Editors. 9th ed. New York: Fitzpatrick's Dermatology McGraw Hill. 2019:734-750.
  2. Porter RJ, Meldrum BS. Antiseizure Drugs. In: Katzung BG, Masters SB, Trevor AJ, editor. Basic & Clinical Pharmacology. 12th ed. New York: Mcgraw-Hill Education. 2012:403-427.
  3. Mitra-Gosh T, Callisto SP, Lamba JK, Remmel RP, Birnbaum AK, Barbarino JM, et al. PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics. Pharmacogenetics and Genomics. 2020:30(4):81-90.
  4. Kc KK, Limbu T, Maskay SS, Bhasima A, Acharya SP. Lamotrigine induced toxic epidermal necrolysis: a case report. Ann Med Surg 2020;60(1):468-470.
  5. Naisbitt DJ, Farrell J, Wong G, Depta JPH, Dodd CC, Hopkins JE, et al. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol. 2003;111(6):1393-1403.
  6. Gaeta F, Alonzi C, Valluzzi RL, Viola M, Elia M, Romano A. Hypersensitivity to lamotrigine and nonaromatic anticonvulsant drugs: a review. Curr Pharm Des. 2008;14(27):2874-882.
  7. Zhang Z, Li S, Zhang Z, Yu K, Duan X, Long L, et al. Clinical features, risk factors and prognostic markers of drug-induced liver injury in a patient with Stevens-Johnson syndrome/toxic epidermal necrolysis. Indian J Dermatol. 2020;65(4):247-78.
  8. Lim JK, Saliba L, Smith MJ, McTavish J, Raine C, Curtin P. Normal saline wound dressing--is it really normal?. Br J Plast Surg. 2000;53(1):42-45.
  9. Pullar JM, Carr AC, Vissers MCM. The roles of vitamin C in skin health. Nutrients. 2017;9(8):866.
  10. Duarte TL, Cooke MS, Jones GD. Gene expression profiling reveals new protective roles for vitamin C in human skin cells. Free Radic Biol Med. 2009;46(1):78-87.
  11. Alvarado AM, Navarro SA. Complex B vitamins: physiology and therapeutic effect on pain. American Journal of Pharmacological Sciences. 2016;4(2):20-27.
  12. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585-601.
  13. Tiaka EK, Papanas N, Manolakis AC, Georgiadis GS. Epidermal growth factor in the treatment of diabetic foot ulcers: an update. Perspect Vasc Surg Endovasc Ther. 2012;24(1):37-44.
  14. Nabu EKY, Mahartini NN, Wirawati IAP, Herawati S, Pardosi BBH, Prabawa IPY. Gaucher's disease in a 4-year-old child at Sanglah General Hospital, Bali, Indonesia. Bali Medical Journal. 2021;10(2):724-727.
  15. Purnamawati S, Febriana SA, Danarti R, Saefuddin T. Topical Treatment for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review. Bali Medical Journal. 2016;5(1):82–90.
  16. Sudarsa PSS, Puspawati NMD, Purnama NKR, Sanjaya IGPH, Hamid ARRH. Toxic Epidermal Necrolysis (TEN) in an elderly with comorbidities: a case report. Bali Medical Journal. 2020;9(1):323–326.
  17. Aninditya AD, Baskoro A. A Stevens-Johnson syndrome due to rifampicin in a patient with acquired immune deficiency syndrome (AIDS) and pulmonary tuberculosis. Bali Medical Journal. 2023;12(2):1533–1537.

How to Cite

Mathonie, M., Claudia, G., & Wisan, A. B. (2023). Lamotrigine-induced Stevens-Johnson Syndrome Toxic Epidermal Necrolysis (SJS/TEN) overlap with transaminitis in an Asian female: a case report. Intisari Sains Medis, 14(2), 612–615.




Search Panel